{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T06:33:42Z","timestamp":1773297222179,"version":"3.50.1"},"reference-count":68,"publisher":"Japanese Pharmacological Society","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pharmacol Sci"],"published-print":{"date-parts":[[2008]]},"DOI":"10.1254\/jphs.08r11fm","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T05:56:19Z","timestamp":1229925379000},"page":"426-432","source":"Crossref","is-referenced-by-count":17,"title":["Basic and Translational Research on Proteinase-Activated Receptors: The Role of Thrombin Receptor in Cerebral Vasospasm in Subarachnoid Hemorrhage"],"prefix":"10.1254","volume":"108","author":[{"given":"Yasutoshi","family":"Kai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomio","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Kanaide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuya","family":"Hirano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"332","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1 Kassell NF, Sasaki T, Colohan AR, Nazar G. Cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Stroke. 1985;16:562–572.","DOI":"10.1161\/01.STR.16.4.562"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Dorsch NW. The effect and management of delayed vasospasm after aneurysmal subarachnoid hemorrhage. Neurol Med Chir (Tokyo). 1998;38 Suppl:156–160.","DOI":"10.2176\/nmc.38.suppl_156"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Sasaki T, Kassell NF, Yamashita M, Fujiwara S, Zuccarello M. Barrier disruption in the major cerebral arteries following experimental subarachnoid hemorrhage. J Neurosurg. 1985;63:433–440.","DOI":"10.3171\/jns.1985.63.3.0433"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Johshita H, Kassell NF, Sasaki T. Blood-brain barrier disturbance following subarachnoid hemorrhage in rabbits. Stroke. 1990;21:1051–1058.","DOI":"10.1161\/01.STR.21.7.1051"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Pluta RM. Dysfunction of nitric oxide synthases as a cause and therapeutic target in delayed cerebral vasospasm after SAH. Neurol Res. 2006;28:730–737.","DOI":"10.1179\/016164106X152052"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Sasaki T, Wakai S, Asano T, Watanabe T, Kirino T, Sano K. The effect of a lipid hydroperoxide of arachidonic acid on the canine basilar artery. An experimental study on cerebral vasospasm. J Neurosurg. 1981;54:357–365.","DOI":"10.3171\/jns.1981.54.3.0357"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Sato M, Tani E, Fujikawa H, Kaibuchi K. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res. 2000;87:195–200.","DOI":"10.1161\/01.RES.87.3.195"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Miyagi Y, Carpenter RC, Meguro T, Parent AD, Zhang JH. Upregulation of rho A and rho kinase messenger RNAs in the basilar artery of a rat model of subarachnoid hemorrhage. J Neurosurg. 2000;93:471–476.","DOI":"10.3171\/jns.2000.93.3.0471"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-198001000-00001"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1007\/s007010050143"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1097\/00006123-199903000-00029"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Tsurutani H, Ohkuma H, Suzuki S. Effects of thrombin inhibitor on thrombin-related signal transduction and cerebral vasospasm in the rabbit subarachnoid hemorrhage model. Stroke. 2003;34:1497–1500.","DOI":"10.1161\/01.STR.0000070424.38138.30"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Saito I, Ueda Y, Sano K. Significance of vasospasm in the treatment of ruptured intracranial aneurysms. J Neurosurg. 1977;47:412–429.","DOI":"10.3171\/jns.1977.47.3.0412"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1007\/BF01809136"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Inagawa T, Yamamoto M, Kamiya K. Effect of clot removal on cerebral vasospasm. J Neurosurg. 1990;72:224–230.","DOI":"10.3171\/jns.1990.72.2.0224"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.2176\/nmc.23.659"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Findlay JM, Weir BK, Kassell NF, Disney LB, Grace MG. Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1991;75:181–188.","DOI":"10.3171\/jns.1991.75.2.0181"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Sasaki T, Ohta T, Kikuchi H, Takakura K, Usui M, Ohnishi H, et al. A phase II clinical trial of recombinant human tissue-type plasminogen activator against cerebral vasospasm after aneurysmal subarachnoid hemorrhage. Neurosurgery. 1994;35:597–604.","DOI":"10.1227\/00006123-199410000-00004"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kosnik EJ, Hunt WE. Postoperative hypertension in the management of patients with intracranial arterial aneurysms. J Neurosurg. 1976;45:148–154.","DOI":"10.3171\/jns.1976.45.2.0148"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Lennihan L, Mayer SA, Fink ME, Beckford A, Paik MC, Zhang H, et al. Effect of hypervolemic therapy on cerebral blood flow after subarachnoid hemorrhage: a randomized controlled trial. Stroke. 2000;31:383–391.","DOI":"10.1161\/01.STR.31.2.383"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Allen GS, Ahn HS, Preziosi TJ, Battye R, Boone SC, Boone SC, et al. Cerebral arterial spasm: a controlled trial of nimodipine in patients with subarachnoid hemorrhage. New Engl J Med. 1983;308:619–624.","DOI":"10.1056\/NEJM198303173081103"},{"issue":"Suppl 1","key":"22","first-page":"67S","volume":"20","year":"1985","ISSN":"https:\/\/id.crossref.org\/issn\/0306-5251","issn-type":"print"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Takayasu M, Suzuki Y, Shibuya M, Asano T, Kanamori M, Okada T, et al. The effects of HA compound calcium antagonists on delayed cerebral vasospasm in dogs. J Neurosurg. 1986;65:80–85.","DOI":"10.3171\/jns.1986.65.1.0080"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Shibuya M, Suzuki Y, Sugita K, Saito I, Sasaki T, Takakura K, et al. Effect of AT877 on cerebral vasospasm after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1992;76:571–577.","DOI":"10.3171\/jns.1992.76.4.0571"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Sasaki T, Wakai S, Asano T, Takakura K, Sano K. Prevention of cerebral vasospasm after SAH with a thromboxane synthetase inhibitor, OKY-1581. J Neurosurg. 1982;57:74–82.","DOI":"10.3171\/jns.1982.57.1.0074"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Suzuki S, Sano K, Handa H, Asano T, Tamura A, Yonekawa Y, et al. Clinical study of OKY-046, a thromboxane synthetase inhibitor, in prevention of cerebral vasospasms and delayed cerebral ischaemic symptoms after subarachnoid haemorrhage due to aneurysmal rupture: a randomized double-blind study. Neurol Res. 1989;11:79–88.","DOI":"10.1080\/01616412.1989.11739867"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 McGirt MJ, Lynch JR, Parra A, Sheng H, Pearlstein RD, Laskowitz DT, et al. Simvastatin increases endothelial nitric oxide synthase and ameliorates cerebral vasospasm resulting from subarachnoid hemorrhage. Stroke. 2002;33:2950–2956.","DOI":"10.1161\/01.STR.0000038986.68044.39"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Tseng MY, Czosnyka M, Richards H, Pickard JD, Kirkpatrick PJ. Effects of acute treatment with pravastatin on cerebral vasospasm, autoregulation, and delayed ischemic deficits after aneurysmal subarachnoid hemorrhage: a phase II randomized placebo-controlled trial. Stroke. 2005;36:1627–1632.","DOI":"10.1161\/01.STR.0000176743.67564.5d"},{"issue":"3","key":"29","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/S0022-3565(24)37130-7","volume":"283","year":"1997","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Vajkoczy P, Meyer B, Weidauer S, Raabe A, Thome C, Ringel F, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103:9–17.","DOI":"10.3171\/jns.2005.103.1.0009"},{"key":"31","doi-asserted-by":"publisher","DOI":"10.1007\/BF01406044"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Kaku Y, Yonekawa Y, Tsukahara T, Kazekawa K. Superselective intra-arterial infusion of papaverine for the treatment of cerebral vasospasm after subarachnoid hemorrhage. J Neurosurg. 1992;77:842–847.","DOI":"10.3171\/jns.1992.77.6.0842"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Kassell NF, Helm G, Simmons N, Phillips CD, Cail WS. Treatment of cerebral vasospasm with intra-arterial papaverine. J Neurosurg. 1992;77:848–852.","DOI":"10.3171\/jns.1992.77.6.0848"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1007\/s007010050260"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 White RP, Hagen AA, Morgan H, Dawson WN, Robertson JT. Experimental study on the genesis of cerebral vasospasm. Stroke. 1975;6:52–57.","DOI":"10.1161\/01.STR.6.1.52"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 White RP, Chapleau CE, Dugdale M, Robertson JT. Cerebral arterial contractions induced by human and bovine thrombin. Stroke. 1980;11:363–368.","DOI":"10.1161\/01.STR.11.4.363"},{"issue":"4","key":"37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.5551\/jat.10.211","volume":"10","author":"HIRANO K","year":"2003","ISSN":"https:\/\/id.crossref.org\/issn\/1340-3478","issn-type":"print"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38 Hirano K, Nomoto N, Hirano M, Momota F, Hanada A, Kanaide H. Distinct Ca2+<\/sup> Requirement for NO Production between Proteinase-Activated Receptor 1 and 4 (PAR1<\/sub> and PAR4<\/sub>) in Vascular Endothelial Cells. J Pharmacol Exp Ther. 2007;322:668–677.","DOI":"10.1124\/jpet.107.121038"},{"key":"39","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0700763104"},{"key":"40","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FMJ04005X2"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41 Hirano K. The roles of proteinase-activated receptors in the vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol. 2007;27:27–36.","DOI":"10.1161\/01.ATV.0000251995.73307.2d"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42 Maeda Y, Hirano K, Kai Y, Hirano M, Suzuki SO, Sasaki T, et al. Up-regulation of proteinase-activated receptor 1 and increased contractile responses to thrombin after subarachnoid haemorrhage. Br J Pharmacol. 2007;152:1131–1139.","DOI":"10.1038\/sj.bjp.0707435"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43 Kai Y, Hirano K, Maeda Y, Nishimura J, Sasaki T, Kanaide H. Prevention of the hypercontractile response to thrombin by proteinase-activated receptor-1 antagonist in subarachnoid hemorrhage. Stroke. 2007;38:3259–3265.","DOI":"10.1161\/STROKEAHA.107.487769"},{"issue":"7","key":"44","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1139\/y92-137","volume":"70","year":"1992","ISSN":"https:\/\/id.crossref.org\/issn\/0008-4212","issn-type":"print"},{"issue":"4","key":"45","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1097\/00005344-199310000-00015","volume":"22","year":"1993","ISSN":"https:\/\/id.crossref.org\/issn\/0160-2446","issn-type":"print"},{"issue":"6","key":"46","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1476-5381.1995.tb15895.x","volume":"115","year":"1995","ISSN":"https:\/\/id.crossref.org\/issn\/0007-1188","issn-type":"print"},{"key":"47","doi-asserted-by":"publisher","DOI":"10.1172\/JCI116031"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1254\/jphs.FMJ04005X6"},{"key":"49","unstructured":"49 Svendgaard NA, Edvinsson L, Owman C, Sahlin C. Increased sensitivity of the basilar artery to norepinephrine and 5-hydroxytryptamine following experimental subarachnoid hemorrhage. Surg Neurol. 1977;8:191–195."},{"key":"50","doi-asserted-by":"crossref","unstructured":"50 Hara H, Edvinsson L. Perivascular innervation of the cerebral circulation: involvement in the pathophysiology of subarachnoid hemorrhage. Neurosurg Rev. 1987;10:171–179.","DOI":"10.1007\/BF01782043"},{"issue":"3","key":"51","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/S0022-3565(25)13101-7","volume":"277","year":"1996","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3565","issn-type":"print"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1007\/s003290050147"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53 Macdonald RL, Weir BK. A review of hemoglobin and the pathogenesis of cerebral vasospasm. Stroke. 1991;22:971–982.","DOI":"10.1161\/01.STR.22.8.971"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54 Tanishima T. Cerebral vasospasm: contractile activity of hemoglobin in isolated canine basilar arteries. J Neurosurg. 1980;53:787–793.","DOI":"10.3171\/jns.1980.53.6.0787"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55 Ito M. Experimental vasospasms–significance of oxyhemoglobin, fibrin degradation products and breakdown products of white ghost in the pathogenesis of cerebral vasospasms. Treatment of vasospasms with gabexate mesilate and diphenhydramine. Neurol Med Chir (Tokyo). 1980;20:225–236.","DOI":"10.2176\/nmc.20.225"},{"issue":"3","key":"56","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1365-2125.1980.tb01749.x","volume":"10","year":"1980","ISSN":"https:\/\/id.crossref.org\/issn\/0306-5251","issn-type":"print"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57 Allen GS, Henderson LM, Chou SN, French LA. Cerebral arterial spasm. 1. In vitro contractile activity of vasoactive agents on canine basilar and middle cerebral arteries. J Neurosurg. 1974;40:433–441.","DOI":"10.3171\/jns.1974.40.4.0433"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58 Kapp J, Mahaley MS Jr, Odom GL. Cerebral arterial spasm. 2. Experimental evaluation of mechanical and humoral factors in pathogenesis. J Neurosurg. 1968;29:339–349.","DOI":"10.3171\/jns.1968.29.4.0339"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59 Ellis EF, Nies AS, Oates JA. Cerebral arterial smooth muscle contraction by thromboxane A2. Stroke. 1977;8:480–483.","DOI":"10.1161\/01.STR.8.4.480"},{"key":"60","doi-asserted-by":"publisher","DOI":"10.1007\/BF01808827"},{"key":"61","doi-asserted-by":"crossref","unstructured":"61 La Torre E, Patrono C, Fortuna A, Grossi-Belloni D. Role of prostaglandin F2 in human cerebral vasospasm. J Neurosurg. 1974;41:293–299.","DOI":"10.3171\/jns.1974.41.3.0293"},{"key":"62","doi-asserted-by":"crossref","unstructured":"62 Hagen AA, Gerber JN, Sweeley CC, White RP, Robertson JT. Levels and disappearance of prostaglandin F2alpha in cerebral spinal fluid: a clinical and experimental study. Stroke. 1977;8:672–675.","DOI":"10.1161\/01.STR.8.6.672"},{"key":"63","doi-asserted-by":"crossref","unstructured":"63 Walker V, Pickard JD, Smythe P, Eastwood S, Perry S. Effects of subarachnoid haemorrhage on intracranial prostaglandins. J Neurol Neurosurg Psychiatry. 1983;46:119–125.","DOI":"10.1136\/jnnp.46.2.119"},{"key":"64","doi-asserted-by":"publisher","DOI":"10.1161\/hs1201.099525"},{"issue":"2","key":"65","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1365-2125.1979.tb00914.x","volume":"7","year":"1979","ISSN":"https:\/\/id.crossref.org\/issn\/0306-5251","issn-type":"print"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1006\/bbrc.1993.2139"},{"key":"67","doi-asserted-by":"crossref","unstructured":"67 Ide K, Yamakawa K, Nakagomi T, Sasaki T, Saito I, Kurihara H, et al. The role of endothelin in the pathogenesis of vasospasm following subarachnoid haemorrhage. Neurol Res. 1989;11:101–104.","DOI":"10.1080\/01616412.1989.11739870"},{"key":"68","doi-asserted-by":"crossref","unstructured":"68 Maeda Y, Hirano K, Hirano M, Kikkawa Y, Kameda K, Sasaki T, et al. Enhanced contractile response of the basilar artery to platelet-derived growth factor in subarachnoid hemorrhage. Stroke. In press 2009.","DOI":"10.1161\/STROKEAHA.108.530196"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T09:41:51Z","timestamp":1738834911000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jstage.jst.go.jp\/article\/jphs\/108\/4\/108_08R11FM\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":68,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1254\/jphs.08r11fm","relation":{},"ISSN":["1347-8613","1347-8648"],"issn-type":[{"value":"1347-8613","type":"print"},{"value":"1347-8648","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}